US 9556146
Lanthionine synthetase C-like 2-based therapeutics
granted A61KA61K31/4184A61K31/423
Quick answer
US patent 9556146 (Lanthionine synthetase C-like 2-based therapeutics) held by Biotherapeutics, Inc. expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biotherapeutics, Inc.
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4184, A61K31/423, A61K31/4439, A61K31/496